SEC Form D private-offering filing

Enveric Biosciences, Inc.

Name: Enveric Biosciences, Inc. - new SEC Form D private-offering filing, Cambridge, MA
Published: 2026-05-04

A new SEC Form D private-offering notice from Cambridge, MA, a $5,000,002 filer-stated offering target in Biotech. The source filing is one click away.

Enveric Biosciences, Inc. site↗ Verified via SEC Form D

Nasdaq listed clinical stage biotech developing neuroplastogenic small molecule therapeutics for neuropsychiatric disorders

Filed 2026-05-04Filed to raise $5,000,002First money in 2026-04-17Raised so far $5,000,002HQ (as filed) Cambridge, MASector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified enveric.com↗Named in the filing 7 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.